JBIO - Aerovate Therapeutics Market Capitalization

Official company branding of Aerovate Therapeutics (JBIO)

The visualized price action of Aerovate Therapeutics Inc (JBIO) serves as an indicator of the business's health, which relies on robust capital to fund research despite current market uncertainty and the search for new growth vectors. The current market capitalization stands at 1.03. Growth prospects are driven by the development of a convenient inhalation therapy for pulmonary hypertension and the anticipated trial results for the drug AV-101.

JBIO Aerovate Therapeutics, Inc.: Market Value in the range 04/30/2025 - 11/18/2026

Comprehensive metric breakdowns and analytics for Aerovate Therapeutics (JBIO)

- current price and projected stock value:
Fundamental company analysis:JBIO (Aerovate Therapeutics)
Product sample of aerovatetx.com

The development of pulmonary hypertension drugs determines the valuation of Aerovate Therapeutics Inc (JBIO), although reliance on a single project increases volatility. Market capitalization is calculated as the product of the current share price and the total number of shares outstanding. This metric measures the total value of the business in the eyes of investors. Sharp fluctuations in this indicator signal a reassessment of clinical trial risks. The dynamics of the company's valuation on the stock market help identify points of asset overheating.

Key competitors

Market Value Argenx ARGX|BNTX: Market Capitalization|ABVX: Market Valuation|ADMA Biologics (ADMA) - Market Valuation|PTGX (Protagonist Therapeutics Inc) - Market Valuation|IMVT: Market Value|Market Value Kiniksa|Grifols Group - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Therapeutics) - Market Value|Market Capitalization AUPH (auriniapharma.com)|Market Capitalization BioCryst Pharmaceuticals, Inc. BCRX|VERA - Market Value|Market Value DNTH (Dianthus Corp)|pharvaris.com (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc|TRML (tourmalinebio.com) - Market Capitalization|Market Capitalization Intrexon|Market Valuation PHAR (Pharming)|NKTR (Nektar) - Market Value|Market Value upstreambio.com UPB|Market Capitalization zenasbio.com (ZBIO)|IMNM - Market Value|Gossamer Bio Inc (GOSS) - Market Valuation|KalVista Corp (KALV) - Market Value|Market Valuation Septerna Inc|Market Valuation PVLA|Market Capitalization savarapharma.com|Market Value Rigel Pharmaceuticals Inc (RIGL)|AnaptysBio - Market Capitalization|Market Capitalization ATXS (astriatx.com)|enGene Bio (ENGN) - Market Value|RAPT - Market Value|ACRS - Market Capitalization|KYTX (Kyverna Therapeutics, Inc) - Market Valuation|TLSA - Market Capitalization|CABA (Cabaletta Bio, Inc) - Market Capitalization|Market Capitalization VTYX (Ventyx Biosciences)|Market Value Theratechnologies Inc. (THTX)|Market Value AVTX (avalotx.com)|Market Value Eledon Pharmaceuticals, Inc ELDN|Market Capitalization Agenus, Inc. AGEN|CLYM: Market Valuation|ZURA: Market Value|ATYR: Market Capitalization|Market Value Adagene Inc (ADAG)|IMA (Ikena Oncology) - Market Capitalization|Market Capitalization Shattuck Labs|Market Capitalization EQ|Market Value CNTB (Connect Biopharma Holdings Limited)|Market Value immunic-therapeutics.com IMUX|Market Value ATRA (Atara Biotherapeutics Inc)|IFRX: Market Valuation|X4 Pharmaceuticals, Inc. (XFOR) - Market Valuation|ACET: Market Capitalization|CELU - Market Capitalization|Market Value INmune Bio|Market Value Barinthus Biotherapeutics plc BRNS|Market Capitalization KZR|SABS - Market Value|Akari Therapeutics Plc - Market Valuation|enlivex.com (ENLV) - Market Value|QTTB - Market Value|Market Capitalization GeoVax Labs, Inc. GOVX|EDSA: Market Capitalization|iBio Inc - Market Value|CARM (Carisma Therapeutics Inc.) - Market Capitalization|XTL Biopharmaceuticals, Ltd. (XTLB) - Market Capitalization|Market Capitalization BOLT|HCWB (HCW Biologics) - Market Value|Market Capitalization APVO (Aptevo Therapeutics, Inc.)|Market Value AIM|ADTX: Market Valuation|Market Value GRI (GRI Bio Corp)|XRTX: Market Capitalization|Market Capitalization HIND|Market Value Revelation Biosciences, Inc.|Market Capitalization INDP (Indaptus Therapeutics, Inc.)|Market Capitalization SCNI|CALI (CalciMedica Inc) - Market Value|Market Capitalization AFMD (Affimed NV)|ALLK - Market Valuation|HOOKIPA Pharma Inc. - Market Capitalization|Market Value IGMS (igmbio.com)|iTeos Pharma (ITOS) - Market Value|Ocean Bio - Market Value|TCBP (TC BioPharm (Holdings) Plc) - Market Capitalization|Market Capitalization Third Harmonic Bio, Inc.